MTI Ltd. revised earnings guidance for the first half of March 31, 2024, and the full year ending September 30, 2024. For the first half ended March 31, 2024, the company now net sales of ¥13,517 million against previous guidance of ¥13,000 million; Operating income of ¥1,052 million against previous guidance of ¥600 million; Profit attributable to owners of parent of ¥1,683 million against previous guidance of ¥1,240 million and net income per share of ¥30.68 against ¥22.60. The second quarter (cumulative) sales are expected to exceed the previous forecast due to increased sales in the healthcare business and corporate DX support business, among others. Consequently, operating profit, ordinary profit, and profit attributable to owners of parent are expected to significantly exceed the previous forecast.

For the year ending September 30, 2024, the company now the net sales of ¥27,000 million against previous guidance of ¥27,000 million; Operating income of ¥1,800 million against previous guidance of ¥1,000 million; Profit attributable to owners of parent of ¥1,750 million against previous guidance of ¥1,340 million and net income per share of ¥31.90 against ¥24.43. While the full-year sales forecast remains unchanged, will revise upwards forecasts for operating income, ordinary income, and profit attributable to owners of parent. This decision is based on the significant outperformance of the second quarter (cumulative) and the steady expansion of the number of schools introducing our school DX business.